{"id":"https://genegraph.clinicalgenome.org/r/5675ef04-d948-4bc2-9337-894ee789220dv1.0","type":"EvidenceStrengthAssertion","dc:description":"*GBA2* was first reported in relation to autosomal recessive complex hereditary spastic paraplegia in 2010 (Boukaris et al., PMID: 20593214). The reported phenotypes include cerebellar ataxia, mental impairment (including variable intellectual disability, cognitive decline, and dementia in some patients), and early-onset cataracts.  \n\nEight variants (missense, nonsense, frameshift) that have been reported in 13 probands in 5  publications (PMIDs: 20593214, 23332916, 24252062, 23332917, 24337409) are included in this curation. While additional evidence is available in the literature, the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is reported to be loss of function (PMID: 23332916).\n\nIn summary, there is definitive evidence supporting the relationship between *GBA2* and autosomal recessive complex hereditary spastic paraplegia. This has been repeatedly demonstrated in research and clinical diagnostic settings and upheld over time. This classification was approved by the ClinGen Cerebral Palsy GCEP on May 2, 2024 (SOP Version 10).\n\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5675ef04-d948-4bc2-9337-894ee789220d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/0ecc960c-5410-4ad8-ab77-bca41145f5e2","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/0ecc960c-5410-4ad8-ab77-bca41145f5e2_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10113","date":"2025-01-28T21:39:48.305Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/0ecc960c-5410-4ad8-ab77-bca41145f5e2_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10113","date":"2024-05-02T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ecc960c-5410-4ad8-ab77-bca41145f5e2_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ecc960c-5410-4ad8-ab77-bca41145f5e2_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/faaa5a35-7dc5-4247-88e4-fa168fee4678_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332917","rdfs:label":"E","estimatedLodScore":1.23,"family":{"id":"https://genegraph.clinicalgenome.org/r/faaa5a35-7dc5-4247-88e4-fa168fee4678","type":"Family","rdfs:label":"E","member":{"id":"https://genegraph.clinicalgenome.org/r/54ba3b8f-0b98-44a3-93ac-ccebfeae4ef7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332917","rdfs:label":"E: IV:2,3","allele":{"id":"https://genegraph.clinicalgenome.org/r/3d8a752c-f990-4a8a-932c-7cf8aaaae3b9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020944.3(GBA2):c.1018C>T (p.Arg340del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130876"}},"firstTestingMethod":"Homozygosity mapping","secondTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5d7d13c7-2ef1-4ef4-88b3-a907b41249ad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332917","allele":{"id":"https://genegraph.clinicalgenome.org/r/3d8a752c-f990-4a8a-932c-7cf8aaaae3b9"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypeNegativeAlleleNegative":5,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/54ba3b8f-0b98-44a3-93ac-ccebfeae4ef7"}},{"id":"https://genegraph.clinicalgenome.org/r/e63918f0-2266-48cf-aeda-39602d25d359_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332917","rdfs:label":"C","estimatedLodScore":1.1,"family":{"id":"https://genegraph.clinicalgenome.org/r/e63918f0-2266-48cf-aeda-39602d25d359","type":"Family","rdfs:label":"C","member":{"id":"https://genegraph.clinicalgenome.org/r/974fac81-27f2-4215-a0bb-4dfd86fa64e0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332917","rdfs:label":"C:IV:2,3","allele":{"id":"https://genegraph.clinicalgenome.org/r/7a6e5830-3037-4fa9-8732-e30b49570287","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020944.3(GBA2):c.2618G>A (p.Arg873His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130878"}},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7ddfd7bf-7450-4e45-9a8d-3f9364d39461_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332917","allele":{"id":"https://genegraph.clinicalgenome.org/r/7a6e5830-3037-4fa9-8732-e30b49570287"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/974fac81-27f2-4215-a0bb-4dfd86fa64e0"}},{"id":"https://genegraph.clinicalgenome.org/r/e598e224-728a-4b20-a786-92227359adf5_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332916","rdfs:label":"Portuguese","estimatedLodScore":1.75,"family":{"id":"https://genegraph.clinicalgenome.org/r/e598e224-728a-4b20-a786-92227359adf5","type":"Family","rdfs:label":"Portuguese"},"phenotypeNegativeAlleleNegative":14,"phenotypePositiveAllelePositive":1},{"id":"https://genegraph.clinicalgenome.org/r/bfa38e69-5565-48dd-b629-88892fcb197d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24252062","rdfs:label":"Cypriot family","estimatedLodScore":1.7,"family":{"id":"https://genegraph.clinicalgenome.org/r/bfa38e69-5565-48dd-b629-88892fcb197d","type":"Family","rdfs:label":"Cypriot family","member":{"id":"https://genegraph.clinicalgenome.org/r/fad386ed-1794-4a3a-9575-7dbd7f766520","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24252062","rdfs:label":"VI:2,4,5","allele":{"id":"https://genegraph.clinicalgenome.org/r/d7167486-50a1-41e8-925c-8371d5eade1d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020944.3(GBA2):c.1780G>C (p.Asp594His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA145524"}},"firstTestingMethod":"Homozygosity mapping","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/eb1f05ed-64b7-468d-8d9e-848cab4c7d9e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24252062","allele":{"id":"https://genegraph.clinicalgenome.org/r/d7167486-50a1-41e8-925c-8371d5eade1d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/fad386ed-1794-4a3a-9575-7dbd7f766520"},"publishedLodScore":1.81,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/10324e67-c764-4830-8d81-19d2e4a0c2f1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24337409","rdfs:label":"Italian and North African","family":{"id":"https://genegraph.clinicalgenome.org/r/10324e67-c764-4830-8d81-19d2e4a0c2f1","type":"Family","rdfs:label":"Italian and North African","member":{"id":"https://genegraph.clinicalgenome.org/r/0f463db7-2af2-40aa-ad94-e599d585305b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24337409","rdfs:label":"DZ twin and a brother","allele":{"id":"https://genegraph.clinicalgenome.org/r/74a3bafa-25a6-4037-bd00-bafc8c20118c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012424.6(RPS6KC1):c.2048G>C (p.Gly683Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1387557"}},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0007020","obo:HP_0001251","obo:HP_0012391","obo:HP_0031993","obo:HP_0000508","obo:HP_0002061","obo:HP_0001249"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f8a74751-e798-46f8-a77c-fb5cff5bfcca_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24337409","allele":{"id":"https://genegraph.clinicalgenome.org/r/74a3bafa-25a6-4037-bd00-bafc8c20118c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0007020","obo:HP_0000508","obo:HP_0002061","obo:HP_0031993","obo:HP_0012391","obo:HP_0001251","obo:HP_0001249"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0f463db7-2af2-40aa-ad94-e599d585305b"}},{"id":"https://genegraph.clinicalgenome.org/r/93a4bc46-ebee-486c-bcd3-7446bfb49a55_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20593214","rdfs:label":"TUN35","estimatedLodScore":3.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/93a4bc46-ebee-486c-bcd3-7446bfb49a55","type":"Family","rdfs:label":"TUN35","member":{"id":"https://genegraph.clinicalgenome.org/r/d1e0de3d-972a-4d31-9e31-6ea3465150b9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20593214","rdfs:label":"Family TUN35 26 (female)","allele":{"id":"https://genegraph.clinicalgenome.org/r/40ad8430-9558-4e2c-b318-d9b64adf9bf0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020944.3(GBA2):c.1888C>T (p.Arg630Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130873"}},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Complicated HSP","phenotypes":["obo:HP_0000518","obo:HP_0002061","obo:HP_0006986","obo:HP_0001272","obo:HP_0001288","obo:HP_0003484","obo:HP_0001268","obo:HP_0033725","obo:HP_0007020"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7b931afc-9049-4388-bbb5-ba794361b131_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20593214","allele":{"id":"https://genegraph.clinicalgenome.org/r/40ad8430-9558-4e2c-b318-d9b64adf9bf0"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"complicated HSP","phenotypeNegativeAlleleNegative":8,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0003484","obo:HP_0033725","obo:HP_0001288","obo:HP_0001272","obo:HP_0001268","obo:HP_0007020","obo:HP_0006986","obo:HP_0002061","obo:HP_0000518"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/d1e0de3d-972a-4d31-9e31-6ea3465150b9"},"publishedLodScore":3,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/4766c27f-2ec6-41eb-bac3-0de816447d94_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332916","rdfs:label":"Belgium ","estimatedLodScore":2.45,"family":{"id":"https://genegraph.clinicalgenome.org/r/4766c27f-2ec6-41eb-bac3-0de816447d94","type":"Family","rdfs:label":"Belgium ","member":{"id":"https://genegraph.clinicalgenome.org/r/1e45fe95-ce38-4dd4-baf0-7292b7badf55","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332916","rdfs:label":"Ng121","allele":{"id":"https://genegraph.clinicalgenome.org/r/d80a1f7a-d4f4-4ddc-a279-179f94ddc30c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020944.3(GBA2):c.700C>T (p.Arg234Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130874"}},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3231662b-b8d5-45f6-9338-58a65eb5d932_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332916","allele":{"id":"https://genegraph.clinicalgenome.org/r/d80a1f7a-d4f4-4ddc-a279-179f94ddc30c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypeNegativeAlleleNegative":10,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/1e45fe95-ce38-4dd4-baf0-7292b7badf55"}},{"id":"https://genegraph.clinicalgenome.org/r/d36b9f4e-6b30-4578-a69c-47ec7cd775a9_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332916","rdfs:label":"Turkish Family","estimatedLodScore":2.35,"family":{"id":"https://genegraph.clinicalgenome.org/r/d36b9f4e-6b30-4578-a69c-47ec7cd775a9","type":"Family","rdfs:label":"Turkish Family","member":{"id":"https://genegraph.clinicalgenome.org/r/a5cf6a92-90b6-4fed-b5fc-daca5d2984bf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332916","rdfs:label":"F18310","allele":{"id":"https://genegraph.clinicalgenome.org/r/7a4a0f07-76b2-4ca4-b03f-0bb5e8e02a1c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006118.4(HAX1):c.518G>A (p.Trp173Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342593037"}},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8284162d-07b4-48a4-905e-abca7ff40a26_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332916","allele":{"id":"https://genegraph.clinicalgenome.org/r/7a4a0f07-76b2-4ca4-b03f-0bb5e8e02a1c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypeNegativeAlleleNegative":14,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/a5cf6a92-90b6-4fed-b5fc-daca5d2984bf"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a5cf6a92-90b6-4fed-b5fc-daca5d2984bf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8284162d-07b4-48a4-905e-abca7ff40a26","type":"EvidenceLine","dc:description":"Per the neurodevelopmental scoring guidelines, this proband was capped at a score of 2 points.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8284162d-07b4-48a4-905e-abca7ff40a26_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID 26220345","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8284162d-07b4-48a4-905e-abca7ff40a26_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a5cf6a92-90b6-4fed-b5fc-daca5d2984bf"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0f463db7-2af2-40aa-ad94-e599d585305b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8a74751-e798-46f8-a77c-fb5cff5bfcca","type":"EvidenceLine","dc:description":"Per the neurodevelopmental scoring guidelines, this proband was capped at a score of 2 points.\n","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8a74751-e798-46f8-a77c-fb5cff5bfcca_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Figure 2 verifies the activity of the mutation (PMID: 26220345).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/f8a74751-e798-46f8-a77c-fb5cff5bfcca_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0f463db7-2af2-40aa-ad94-e599d585305b"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/82a474e0-46c4-40a3-9d98-f726ba569c72_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4916796-da81-4297-a2f3-8237dd329e65","type":"EvidenceLine","dc:description":"The variant was studied in, and it shows no enzyme activity (PMID: 26220345).","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4916796-da81-4297-a2f3-8237dd329e65_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The tissue distribution of GBA2 mRNA is different between humans and mice. The mouse Gba2 mRNA is abundant in the testis but not the human mRNA. Gba2 knockout mice display misshapen spermatozoa leading to impaired fertility. Subject has three children, which confirms that the glycosylceramide metabolism is less important in spermatogenesis in humans and suggests that β-glucosidase 2 may play a different role in humans. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d4916796-da81-4297-a2f3-8237dd329e65_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332917","allele":{"id":"https://genegraph.clinicalgenome.org/r/9ddcfeaf-fba4-4730-9e43-fc120ae8face","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020944.3(GBA2):c.363C>A (p.Tyr121del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA373419691"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/82a474e0-46c4-40a3-9d98-f726ba569c72","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23332917","rdfs:label":"ID# Tun_12167","allele":{"id":"https://genegraph.clinicalgenome.org/r/9ddcfeaf-fba4-4730-9e43-fc120ae8face"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d4916796-da81-4297-a2f3-8237dd329e65_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/974fac81-27f2-4215-a0bb-4dfd86fa64e0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ddfd7bf-7450-4e45-9a8d-3f9364d39461","type":"EvidenceLine","dc:description":"The variant was studied in, and it shows no enzyme activity (PMID: 26220345).","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ddfd7bf-7450-4e45-9a8d-3f9364d39461_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The third mutation is a substitution (p.Arg873His) occurring within the COOH-terminal (residues 500–886), a region apparently very conserved across different species implying its importance in the function of the protein.(PMID:11489889)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7ddfd7bf-7450-4e45-9a8d-3f9364d39461_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/974fac81-27f2-4215-a0bb-4dfd86fa64e0"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fad386ed-1794-4a3a-9575-7dbd7f766520_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb1f05ed-64b7-468d-8d9e-848cab4c7d9e","type":"EvidenceLine","dc:description":"There is mouse model with functional evidence (PMID: 26220345) as well as studies identifying loss of enzyme activity (PMID: 30308956). ","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb1f05ed-64b7-468d-8d9e-848cab4c7d9e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The researchers identified that the c.1780G>C mutation in GBA2 significantly reduces NLGase activity both inside cells and on the plasma membrane. This mutation leads to a twofold increase in GlcCer levels, predominantly the C16 species, in patient-derived cells (PMID: 30308956). \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/eb1f05ed-64b7-468d-8d9e-848cab4c7d9e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fad386ed-1794-4a3a-9575-7dbd7f766520"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d1e0de3d-972a-4d31-9e31-6ea3465150b9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b931afc-9049-4388-bbb5-ba794361b131","type":"EvidenceLine","dc:description":"No detectable GBA2 activity could be observed in the cells of subject FSP824-V.14 compared to healthy controls, indicating a complete loss of function by the mutation. Complete loss of function was also evidenced in nontransformed leukocytes of individuals TUN35 (PMID: 23332916).","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b931afc-9049-4388-bbb5-ba794361b131_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"No detectable GBA2 activity could be observed in the cells of subject FSP824-V.14 compared to healthy controls, indicating a complete loss of function by the mutation. Complete loss of function was also evidenced in nontransformed leukocytes of individuals TUN35 (PMID: 23332916).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7b931afc-9049-4388-bbb5-ba794361b131_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d1e0de3d-972a-4d31-9e31-6ea3465150b9"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/54ba3b8f-0b98-44a3-93ac-ccebfeae4ef7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d7d13c7-2ef1-4ef4-88b3-a907b41249ad","type":"EvidenceLine","dc:description":"The variant was studied in, and it shows no enzyme activity (PMID: 26220345).","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d7d13c7-2ef1-4ef4-88b3-a907b41249ad_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.Arg340∗ and p.Tyr121∗ nonsense mutations leading to a protein truncated by 67% and 86%, respectively. The resulting enzyme is very likely to be non-functional. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5d7d13c7-2ef1-4ef4-88b3-a907b41249ad_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/54ba3b8f-0b98-44a3-93ac-ccebfeae4ef7"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1e45fe95-ce38-4dd4-baf0-7292b7badf55_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3231662b-b8d5-45f6-9338-58a65eb5d932","type":"EvidenceLine","dc:description":"Per the neurodevelopmental scoring guidelines, this proband was capped at a score of 2 points.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3231662b-b8d5-45f6-9338-58a65eb5d932_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant was studied in PMID- 26220345","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3231662b-b8d5-45f6-9338-58a65eb5d932_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1e45fe95-ce38-4dd4-baf0-7292b7badf55"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/0ecc960c-5410-4ad8-ab77-bca41145f5e2_experimental_evidence_line","type":"EvidenceLine","specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0}],"evidenceStrength":"Definitive","sequence":9881,"specifiedBy":"GeneValidityCriteria10","strengthScore":12,"subject":{"id":"https://genegraph.clinicalgenome.org/r/au_OT9JtkTE","type":"GeneValidityProposition","disease":"obo:MONDO_0015150","gene":"hgnc:18986","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_0ecc960c-5410-4ad8-ab77-bca41145f5e2-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}